1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. COHERUS BIOSCIENCES INC
Coherus Biosciences Inc XNAS: CHRS

Coherus Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and o...

Read More
1.69 0.16 (10.46%)
138.03% Gain from 52W Low
3.8M
XNAS Volume
High volume+gain today

XNAS 09 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Coherus Biosciences Inc is on 13 Jan 2026 for the purpose of 44th Annual J.P. Morgan Healthcare Conference See details
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Affordable Valuation
58.5 / 100
Momentum Score
Technically Bullish
73.3 / 100
Turnaround Potential These stocks have average financials with good valuations and momentum, indicating turnaround potential View Similar Embed DVM
Analyst Price Target
6
1Yr Price target upside is 236%
3 analysts

27

S

4

W

1

O

3

T

SWOT Analysis

Coherus Biosciences Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..